Upcoming Events
Prescient Therapeutics – Live Investor Briefing
Monday, 20th October 11am (AEDT)
Live Investor Briefing
Please join Prescient Therapeutics CEO James McDonnell for an investor briefing.
Speaker
James McDonnell
CEO
Recent Events
Felix Gold (ASX: FXG) Webcast Replay
10th October 2025
Live Investor Briefing
In this session Felix Gold Executive Director Joseph Webb discussed why the company holds what we believe to be the premier antimony asset in the United States.
Speaker
DR Gerard Dyson
Managing Director – Spectur Limited (ASX: SP3)
Felix Gold (ASX: FXG) Webcast Replay
18th September 2025
Live Investor Briefing
In this session Felix Gold Executive Director Joseph Webb discussed why the company holds what we believe to be the premier antimony asset in the United States.
Speaker
DR Gerard Dyson
Managing Director – Spectur Limited (ASX: SP3)
Felix Gold (ASX: FXG) Webcast Replay
9th September 2025
Live Investor Briefing
In this session Felix Gold Executive Director Joseph Webb discussed why the company holds what we believe to be the premier antimony asset in the United States.
Speaker
DR Gerard Dyson
Managing Director – Spectur Limited (ASX: SP3)
Prescient Therapeutics (ASX: PTX) Webcast Replay
22nd July 2025
Live Investor Briefing
In this session Prescient CEO James McDonnell discusses the outstanding PTX-100 Phase 1b results including the 64% tumor halt or reduction for a cancer considered a ‘death sentence’.
Speaker
DR Gerard Dyson
Managing Director – Spectur Limited (ASX: SP3)
Felix Gold (ASX: FXG) Webcast Replay
12th June 2025
Live Investor Briefing
In this session Felix Gold Executive Director Joseph Webb discussed why the company holds what we believe to be the premier antimony asset in the United States.
Speaker
DR Gerard Dyson
Managing Director – Spectur Limited (ASX: SP3)
Felix Gold (ASX: FXG) Webcast Replay
30th May 2025
Live Investor Briefing
In this session Felix Gold Executive Director Joseph Webb discussed why the company holds what we believe to be the premier antimony asset in the United States.
Speaker
DR Gerard Dyson
Managing Director – Spectur Limited (ASX: SP3)
Prescient Therapeutics (ASX: PTX) Webcast Replay
29th May 2025
Live Investor Briefing
In this session Prescient CEO James McDonnell discusses why the First Patient Dosed marks a significant milestone in the commencement of the PTX-100 Phase 2a study, bringing a potential treatment one step closer to a current unmet need.
Speaker
DR Gerard Dyson
Managing Director – Spectur Limited (ASX: SP3)
MDF Global Q&A Update
27th May 2025
Live Investor Briefing
In this session MDF Global Managing Director Joe Webb discussed their plans to become possibly the largest exploration company on the planet within 5 years.
Speaker
DR Gerard Dyson
Managing Director – Spectur Limited (ASX: SP3)
MDF Global Q&A Update
19 May 2025
Live Investor Briefing
In this session MDF Global Managing Director Joe Webb discussed their plans to become possibly the largest exploration company on the planet within 5 years.
Speaker
DR Gerard Dyson
Managing Director – Spectur Limited (ASX: SP3)
Felix Gold (ASX: FXG) Webcast Replay
4th April 2025
Live Investor Briefing
In this session Felix Gold Executive Director Joseph Webb discussed why the company holds what we believe to be the premier antimony asset in the United States.
Speaker
DR Gerard Dyson
Managing Director – Spectur Limited (ASX: SP3)
Prescient Therapeutics Webcast Replay
26th March 2025
Live Investor Briefing
In this session Prescient Therapeutics (ASX: PTX) CEO James McDonnell provides investors with a company update.
Speaker
DR Gerard Dyson
Managing Director – Spectur Limited (ASX: SP3)
Xsights Q&A Update
28th March 2025
Live Investor Briefing
In this session Xsights Co-Founder and CEO Steve Wildisen provides investors with a company update.
Speaker
DR Gerard Dyson
Managing Director – Spectur Limited (ASX: SP3)
Connecting quality investors and innovative companies to facilitate mutual wealth creation with trust and transparency
Send me information on new events as they become available
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.